
Kanzal ImanLahore University of Management Sciences | LUMS · Department of Biology
Kanzal Iman
PhD Biomedical Informatics
About
7
Publications
2,775
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
129
Citations
Citations since 2017
Introduction
Graduated from Lahore University of Management Sciences (LUMS) in PhD Biomedical informatics. The area of my research has been Computational Proteomics. I have worked on developing a pipeline that integrates Sequence-based and Structural Proteomics.
Additional affiliations
August 2017 - present
Education
July 2014 - July 2016
July 2010 - July 2014
July 2008 - July 2010
Publications
Publications (7)
Mosquitoes act as vectors for the transmission of various infectious pathogens. The associated diseases are prevalent in tropical and subtropical regions of the world and can be prevented by effective vector control and management. Natural compounds have become a potential alternative to synthetic repellents that are unsafe and harmful to the envir...
PERCEPTRON is a next-generation freely available web-based proteoform identification and characterization platform for top-down proteomics (TDP). PERCEPTRON search pipeline brings together algorithms for (i) intact protein mass tuning, (ii) de novo sequence tags-based filtering, (iii) characterization of terminal as well as post-translational modif...
Top-Down Proteomics (TDP) is an emerging proteomics protocol that involves identification, characterization, and quantitation of intact proteins using high-resolution mass spectrometry. TDP has an edge over other proteomics protocols in that it allows for: (i) accurate measurement of intact protein mass, (ii) high sequence coverage, and (iii) enhan...
Hepatitis C compromises the quality of life of more than 350 million individuals worldwide. Over the last decade, therapeutic regimens for treating hepatitis C virus (HCV) infections have undergone rapid advancements. Initially, structure‐based drug design was used to develop molecules that inhibit viral enzymes. Subsequently, establishment of cell...
Ebola virus disease (EVD), caused by Ebola viruses, resulted in more than 11500 deaths according to a recent 2018 WHO report. With mortality rates up to 90 %, it is nowadays one of the most deadly infectious diseases. However, no FDA approved Ebola drugs or vaccines are available yet with the mainstay of therapy being supportive care. The high fata...
Objective and Background: Inhibition of acetylcholinesterase (AChE) has gained much importance since the discovery of the involvement of peripheral anionic site as an allosteric regulator of AChE. Characterized by the formation of β-amyloid plaques, Alzheimer's disease (AD) is currently one of the leading causes of death across the world. Progressi...
Breast cancer is characterized by an uncontrolled growth of cells in breast tissue. Genes that foster cell growth in breast cells are overexpressed, giving rise to breast tumors. The identification of effective inhibitors represents a rational chemopreventive strategy. The current in silico study provides a pharmacoinformatic approach for the ident...